In today's featured interview from
Antibody Engineering 2013, Geoffrey Yarranton, Chief Scientific Officer and Executive Vice President of Research and Development of Kalobios Pharmaceuticals, Inc talks about how the antibody industry is maturing. He also talks about the many challenges of antibody engineering such as the cost of the goods needed fore development, and how to make antibodies cheaper while increasing the length of which these antibodies remain in the human body and reducing the frequency in which the dose of the antibodies are given in. What does this mean for the future of antibody engineering? Watch the interview to find out:
The
25th Annual Antibody Engineering Therapeutics Event will take place December 7-11, 2014 in Huntington Beach, California. To find out more about this year’s speakers and topics,
download the Agenda.
If you'd like to join us, as a reader of this blog, when you register and mention code
XD14172BLOG, you’ll
save 20% off the standard rate.
|
Share this article with your social network, just click below to share now!
|
|
|
No comments :
Post a Comment